← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 12, 2015Last known activity
Jun 22, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (13)
- NCT05960110Reponsible party - principal investigatorPhase 3Jun 22, 2023
- NCT05960110Lead sponsorPhase 3Jun 22, 2023
- NCT05648422Lead sponsorN/AJan 16, 2023
- NCT05648422Reponsible party - principal investigatorN/AJan 16, 2023
- NCT05648422Study directorN/AJan 16, 2023
- NCT05688618Lead sponsorN/ANov 16, 2022
- NCT05688618Reponsible party - principal investigatorN/ANov 16, 2022
- NCT05247034Reponsible party - principal investigatorN/AJun 4, 2021
- NCT05247034Lead sponsorN/AJun 4, 2021
- NCT05247034Study directorN/AJun 4, 2021
- NCT03933709Reponsible party - principal investigatorN/AJan 12, 2015
- NCT03933709Study directorN/AJan 12, 2015
- NCT03933709Lead sponsorN/AJan 12, 2015
Details
- Last known activity
- Jun 22, 2023